Trade BioNTech ^BNTX

BioNTech (NASDAQ:BNTX) Stock Price Target Lowered at UBS Group - Stock Observer

Morgan Stanley Issues Pessimistic Forecast for BioNTech (NASDAQ:BNTX) Stock Price

BioNTech (NASDAQ:BNTX) Stock Price Target Lowered at Wells Fargo & Company

BioNTech Earnings: Guidance Narrowed Higher Despite Lower Covid Vaccine Sales | Morningstar

BioNTech (BNTX) Enters First Global Phase 3 Trial For New Breast Cancer Combo

Moderna Climbs 5% Ahead of Earnings, Pfizer Eases Despite Raised Outlook, Merck Slides 2% Amid New Phase 3 Trial

BioNTech Q3 Earnings Call Highlights

BioNTech (BNTX) Q3 2026 Earnings Date, Time & Estimates

BioNTech Reports Q3 Net Profit; Revenue Falls 15% On Lower COVID-19 Vaccine Demand

BioNTech Q3 Results Show Return To Profitability; Oncology Programs Advance

BioNTech Lifts Outlook on Cancer Drug Milestone Payments (1)

Critical Review: BioNTech (NASDAQ:BNTX) & I-Mab (NASDAQ:NBP) - Zolmax

Stocktwits Pharma Pulse: Biotech Beats The Broader Market - Novo, Pfizer And Moderna Earnings Up Next

Head to Head Contrast: I-Mab (NASDAQ:NBP) & BioNTech (NASDAQ:BNTX) - Daily Political

BioNTech founders receive science award - Türkiye News

Travere Therapeutics (NASDAQ:TVTX) versus BioNTech (NASDAQ:BNTX) Head to Head Contrast - Daily Political

Head to Head Analysis: Xencor (NASDAQ:XNCR) & BioNTech (NASDAQ:BNTX) - Stock Observer

BioNTech (BNTX) Posts Fresh Cancer Trial Progress, Is It Still 24% Below Fair Value?

Head and Neck Squamous Cell Carcinoma Market Size in the 7MM is projected to reach nearly USD 2,560 million by 2036, growing at a CAGR of 10.5% during 2026-2036 | DelveInsight | ABNewswire

BioNTech (BNTX) Phase 3 Breast Cancer Win Comes With A Lung Safety Warning

Financial Comparison: BioNTech (NASDAQ:BNTX) & Travere Therapeutics (NASDAQ:TVTX) - Markets Daily

The $1.5 Billion Question Facing Tempus AI Ahead of Nov. 2 Earnings

BioNTech (BNTX) Projected to Release Quarterly Earnings on Tuesday

BioNTech SE Sponsored ADR $BNTX Stock Sold by Robeco Institutional Asset Management B.V.

Moderna Tumbles 7% as Cancer Vaccine Selloff Deepens; BioNTech Falls 3%, Pfizer Holds Steady

BioNTech, DualityBio Breast Cancer Drug Meets Phase 3 Trial Goal But Shows Higher Lung Disease Rate

BioNTech, Bristol Myers' Pumitamig Shows 36.7% Response Rate In Phase 2 NSCLC Trial

BioNTech (BNTX) Expanded Its Oncology Pipeline, Is It Still 25% Below Fair Value?

Berenberg Bank Sticks to Their Hold Rating for Qiagen (QGEN)

Sterling Capital Management LLC Acquires 88,344 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

7,751 Shares in Gilead Sciences, Inc. $GILD Bought by NBT Bank N.A. - Daily Political

Gilead Sciences, Inc. $GILD Stock Holdings Raised by Royal Fund Management LLC - Zolmax

Gilead Sciences, Inc. $GILD Stock Bought by Royal Fund Management LLC - Markets Daily

Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic cancer: the randomized phase 2 AMPLIFY-7P trial

Moderna Tumbles 25% After Apparent Early Leak of Melanoma Vaccine Data; BioNTech Dips, Pfizer Edges Higher

BioNTech Expands Phase 3 Breast Cancer Trial Through Collaboration With Gilead

BioNTech Advances Phase 3 Clinical Trial of Pumitamig in Combination with Gilead's TROP2-Directed ADC Sacituzumab Govitecan in Triple-Negative Breast Cancer | Morningstar

BioNTech (BNTX) Heads To ESMO 2026 With First ROSETTA Lung 107 Data

BNTX: Oncology Execution Matters Most, Cost Cuts Back The Path To Profits

Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline

Trial Miss Might Change The Case For Investing In BioNTech Stock (BNTX)

BioNTech SE Sponsored ADR $BNTX Shares Acquired by Assenagon Asset Management S.A.

BioNTech (NASDAQ:BNTX) Stock Gets Price Target Reduction from Canaccord Genuity Group - Markets Daily

Moderna Tumbles 10% as Profit Taking Hits Cancer Vaccine Rally; BioNTech Eases, Pfizer Stays Put

Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher

BioNTech (BNTX), What Is Behind The Latest Attention?

BioNTech Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into BioNTech (BNTX) | Morningstar

Canaccord Genuity Group Has Lowered Expectations for BioNTech (NASDAQ:BNTX) Stock Price

BioNTech (NASDAQ:BNTX) Stock Price Target Cut by Canaccord Genuity Group - Daily Political

BioNTech (BNTX) Is Down 7.0% After mRNA Cancer Trial Misses PFS Goal Has The Bull Case Changed?

Critical Analysis: MiMedx Group (NASDAQ:MDXG) vs. BioNTech (NASDAQ:BNTX) - Daily Political

BioNTech's mRNA Cancer Therapy Fails Key Trial Objective in Head and Neck Cancer, ETPharma

What Does BioNTech (BNTX) Trial Miss Mean For Its Oncology Pipeline?

Sivik Global Healthcare LLC Makes New $2.16 Million Investment in BioNTech SE Sponsored ADR $BNTX

BioNTech (NASDAQ:BNTX) Shares Down 5.5% - Here's What Happened

BioNTech mRNA cancer immunotherapy misses first objective in key study

BioNTech Shares Fall 5% as BNT113 Cancer Trial Misses Progression-Free Survival Endpoint

BioNTech stock falls after cancer trial misses key endpoint

BioNTech's BNT113 Misses Progression-Free Survival Endpoint In Phase 3 Head And Neck Cancer Trial

BioNTech Continues AHEAD-MERIT Trial Despite BNT113's PFS Endpoint Miss

Moderna Is Now Worth More Than 3X as Much as BioNTech. Which Biotech Stock Is the Smarter Pick?

BioNTech (NASDAQ:BNTX) Research Coverage Started at Argus - Stock Observer

BioNTech (NASDAQ:BNTX) CEO Sells $2,300,640.00 in Stock - Markets Daily

BioNTech (NASDAQ:BNTX) CEO Sells 27,000 Shares of Company Stock - Markets Daily

BioNTech (NASDAQ: BNTX) CEO sells all direct shares under trading plan - Stock Observer

Moderna stock jumps on planned national cancer vaccine effort

Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up

12,163 BioNTech SE Sponsored ADR $BNTX Shares Sold by Crocodile Capital Partners GmbH - Daily Political

Insider Selling: BioNTech (NASDAQ:BNTX) CEO Sells $7,000,560.00 in Stock - Daily Political

BioNTech (NASDAQ:BNTX) Now Covered by Argus

BioNTech (NASDAQ:BNTX) Stock Picked Up by Analysts at Argus - Zolmax

Is BioNTech (BNTX) Undervalued On Pipeline Promise Despite Revenue Of €2,650.0 Million And Losses?

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Stock Now Rated "Moderate Buy" by Wall Street Analysts - Daily Political

BioNTech (NASDAQ:BNTX) CEO Ugur Sahin Sells 24,000 Shares of Stock

Is BioNTech (NasdaqGS:BNTX) Overvalued As Sales Face A Reset?

BNTX Maintained by Morgan Stanley -- Price Target Lowered to $11

BioNTech (NASDAQ: BNTX) CEO sells 93,000 shares under preplanned deal - Markets Daily

BioNTech (NASDAQ:BNTX) Stock: Insider Ugur Sahin Sells 72,000 Shares

Moderna Is Up 545% in 2026: Take Profits Now, or Keep Buying?

Micron Stock Price Forecast 2026–2030: Can AI Memory Demand Reverse a 26% Week-to-Date Sell-Off?

Will Gold Hit $5,000 Again Before the End of 2026?

Arm Holdings Stock Forecast 2026–2030: Can Data-Center Royalty Growth Drive a Recovery?

Is Gold Still a Safe Haven? What Traders Should Know

Boeing Stock Forecast 2026–2030: Can a Record $745 Billion Backlog Reverse BA’s 11% Earnings Sell-Off?

Is Oracle a Good Buy Right Now? Growth, Valuation and Long-Term Risks

Best Stock CFD Broker in 2026: 9 Platforms Compared

Is SpaceX a Good Stock to Buy in 2026?

Best Gold Stock to Buy Now: 6 Gold Stocks to Watch in 2026

Moderna Stock Soars 177% as Cancer Vaccine Delivers a Landmark Phase 3 Win

Nasdaq Falls 5.52% as AI Selloff Drives S&P 500’s Worst Day Since April 2025

Nvidia Stock Falls 9.26% to $181.60 as Data Center Concerns Hit AI Shares

AppLovin Stock Soars 31% as Record Revenue and a $3.2 Billion Buyback Defy the AI Sell-Off

Oil Price Today Rebounds Toward $100 as New Tanker Attacks Revive Supply Fears

Tesla Plans Cybertruck Wind-Down in Texas as Cybercab Takes Priority

Gold Price Today: Gold Falls Near $4,044 as Oil Rebounds Ahead of US Jobs Data

Dow Jumps 1,569 Points as Democratic Sweep Lifts US Stocks

Gold Price Today: Bullion Rises Above $4,100 as Treasury Yields Fall